Business Context and Reporting Period
This Form 8-K Current Report was filed by WellPoint, Inc. (now known as Elevance Health, Inc.) on December 9, 2004. The report details a significant capital market transaction executed on December 6, 2004, involving the private placement of senior unsecured notes.
Key Financial Metrics and Transaction Details
The Company issued a total of $1.6 billion in aggregate principal amount of notes across four series. The transaction generated net proceeds of $1,583,727,000 after deducting discounts for initial purchasers.
| Note Series | Principal Amount | Interest Rate | Maturity Date |
|---|---|---|---|
| 2007 Notes | $300,000,000 | 3.750% | December 14, 2007 |
| 2009 Notes | $300,000,000 | 4.250% | December 15, 2009 |
| 2014 Notes | $500,000,000 | 5.000% | December 15, 2014 |
| 2034 Notes | $500,000,000 | 5.950% | December 15, 2034 |
The filing does not provide specific data on revenue, operating profit, cash flow from operations, or existing debt levels prior to this transaction.
Material Changes and Debt Structure
The primary material change is the incurrence of new long-term debt obligations. The notes are unsecured and unsubordinated, ranking equally with existing senior credit facilities and senior to future subordinated debt. However, they are effectively subordinated to any future secured indebtedness and all liabilities of the Company's subsidiaries, as the notes are not guaranteed by subsidiaries.
Outlook, Risks, and Unusual Items
- Redemption Rights: The Company retains the option to redeem the 2009, 2014, and 2034 Notes at a price equal to the greater of 100% of the principal or the present value of remaining payments discounted at the treasury rate plus a spread (ranging from 12.5 to 20 basis points).
- Events of Default: Default triggers include failure to pay principal or interest (with a 30-day grace period for interest), breach of indenture terms (60-day cure period), or bankruptcy proceedings.
- Registration Rights: The Company agreed to file a registration statement for the resale of the notes within 90 days of the closing.
- Related Parties: Initial purchasers and their affiliates have provided various banking and advisory services to the Company, including acting as financial advisors for the demutualization and the acquisition of Trigon Healthcare, Inc.
Investor Verification Checklist
- Verify the exact net proceeds received ($1,583,727,000) against the gross principal amount ($1.6 billion) to confirm the discount rate paid to initial purchasers.
- Review the Indenture (Exhibit 4.1) for specific covenants regarding the incurrence of additional indebtedness, as the filing states the Indenture does not prohibit or limit such incurrence.
- Confirm the status of the registration statement for resale, which was required to be filed within 90 days of December 6, 2004.
- Assess the impact of the new debt service obligations (interest payments beginning June 2005) on the Company's liquidity and cash flow.